Expression, purification, and characterization of recombinant human factor X

被引:22
作者
Rudolph, AE [1 ]
Mullane, MP [1 ]
PorcheSorbet, R [1 ]
Miletich, JP [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MED,DIV LAB MED,ST LOUIS,MO 63110
关键词
D O I
10.1006/prep.1997.0752
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A system is described for producing recombinant factor X with properties very similar to human plasma factor X, Optimization of the expression system for factor X resulted in the finding that human kidney cells (293 cells) are superior to the widely utilized baby hamster kidney cells (BHK cells) for the expression of functional factor X, It was also determined that production of factor X by 293 cells requires the substitution of the -2 residue (Thr --> Arg) which affords the removal of the factor X propeptide, Purification of recombinant and plasma factor X is accomplished using a calcium-dependent monoclonal antibody directed against the gla domain, The proteins are comparable by sodium dodecyl sulfate polyacrylamide gel electrophoresis, The rate and extent of activation by the factor X coagulant protein from Russell's viper venom and by factors Ma and VIIIa are similar; activation of the recombinant protein by VIIa and tissue factor is mildly faster, The activated enzymes have the same activity toward a chromogenic substrate and the biologic substrate, prothrombin, Both enzymes leave the same apparent affinity for the activated platelet surface as judged by their ability to activate prothrombin, Finally, inhibition by antithrombin, with or without heparin, and inhibition by the tissue factor pathway inhibitor are equivalent, Recombinant factor X produced by this method is therefore well suited for probing structure-function relationships by mutational analysis, (C) 1997 Academic Press.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 28 条
[1]  
BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497
[2]  
BROZE GJ, 1988, BLOOD, V71, P335
[3]  
CRAIG PA, 1989, J BIOL CHEM, V264, P5452
[4]   ACTIVATION OF HUMAN FACTOR-X (STUART FACTOR) BY A PROTEASE FROM RUSSELLS VIPER VENOM [J].
DISCIPIO, RG ;
HERMODSON, MA ;
DAVIE, EW .
BIOCHEMISTRY, 1977, 16 (24) :5253-5260
[5]  
FASS DN, 1982, BLOOD, V59, P594
[6]   NEW TECHNIQUE FOR ASSAY OF INFECTIVITY OF HUMAN ADENOVIRUS 5 DNA [J].
GRAHAM, FL ;
VANDEREB, AJ .
VIROLOGY, 1973, 52 (02) :456-467
[7]  
GRIARD TJ, 1989, NATURE, V338, P518
[8]  
JESTY J, 1974, J BIOL CHEM, V249, P5614
[9]   EVIDENCE THAT AN ARG79-]GLN SUBSTITUTION IN HUMAN FACTOR-VII IS NOT ASSOCIATED WITH A REDUCTION IN COAGULANT ACTIVITY [J].
KAZAMA, Y ;
FOSTER, DC ;
KISIEL, W .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (06) :697-702
[10]  
Kim DJ, 1996, THROMB HAEMOSTASIS, V75, P313